However, there is evidence in numerous papers suggesting the existence of a relation between copper accumulation in the human body at aging in those individuals with a predisposition to copper metabolic abnormalities that can be identified by having higher than normal levels of non-ceruloplasmin copper and the relationship with AD development. This evidence concerns the gene CP and Alzheimer disease.